Global Molecular Diagnostics Market with Focus on Infectious Diseases

(HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook

----------------------------------------- (2016-2020)

Industry Research by Koncept Analytics

1

September 2016

Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) & Genetic Testing: Industry Analysis & Outlook (2016-2020)

Executive Summary

2Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) &

Genetic Testing: Industry Analysis & Outlook (2016-2020)

Diagnosis is the identification of the nature and cause of a certain phenomena. It involves two different types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market. Asia-Pacific is expected to register the highest growth rate in expansion of molecular diagnostics in the coming years.

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market includes increasing clinical microbiological laboratories in developing nations, next generation sequencing, and increase in sale of point of care devices.

The report offers an in-depth analysis of the “Global Molecular Diagnostics Market”. It covers the regional and global aspect of the market, along with major focus on infectious and genetic testing. Competition is concentrated in the hands of few major companies, of which Roche Holding, Abbott Laboratories, Hologic Inc., and Qiagen have been covered in the report.

The recent outbreak of infectious diseases, like Ebola and swine flu, and increasing requirement of accurate diagnostics is likely to instigate growth of the molecular diagnostics technology globally..

3Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) &

Genetic Testing: Industry Analysis & Outlook (2016-2020)

• The global IVD market’s revenue reached US$.. billion in 2015, increasing from US$.. billion in the previous fiscal year. The market grew at a CAGR of ..% for the period spanning 2011-2015.

• Out of all the IVD technologies, immunochemistry will grew at a CAGR of ..% for the period spanning from 2013-2017.

• The global molecular diagnostics (MD) market revenues reached US$.. billion in 2015, increasing from US$.. billion in the previous fiscal year. The market grew at a CAGR of ..% for the period spanning 2011-2015.

Global IVD Market CAGR by Technology (2013-2017)

Global IVD Market by Value (2011-2015)

Global Molecular Diagnostics Market by Value (2011-2015)

The Molecular Diagnostics market will experience robust growth, attributable to Fast Approvals for Companion Diagnostics (CD) Reagents and rising emergence of infectious diseases..

4Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) &

Genetic Testing: Industry Analysis & Outlook (2016-2020)

• In global MD market, the infectious diseases (HIV, HPV, TB) segment accounted for the maximum revenue share i.e. ..%, followed by oncology segment and genetics accounted with ..% and ..% revenue share respectively.

• The revenue of the HPV testing market reached US$.. million in 2015, increasing from US$.. million in the previous fiscal year. The market grew at a CAGR of ..% for the period spanning 2011-2015.

• The global genetic testing market is expected to reach US$.. billion by 2020, increasing from US$.. billion in 2016. The market is expected to grow at a CAGR of ..% for the period spanning 2016-2020.

Global HPV Market by Value & Volume (2011-2015)

Global MD Market by Application (2015)

Global Genetic Testing Market Forecast by Value (2016-2020)

Koncept AnalyticsCS-36, First Floor, Ansal Plaza

Vaishali, Ghaziabad, U.P. – 201010

T: +91-120-4130959M: +91-9811715635

vikas@konceptanalytics.com

Contact Us:

www.konceptanalytics.com

This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report.

We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.

5Global Molecular Diagnostics Market with Focus on Infectious Diseases (HPV/Chlamydia) &

Genetic Testing: Industry Analysis & Outlook (2016-2020)

Disclaimer